Solventum Co. (NYSE:SOLV) Receives Average Rating of "Hold" from Brokerages

Shares of Solventum Co. (NYSE:SOLV - Get Free Report) have been assigned an average recommendation of "Hold" from the eleven analysts that are currently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has assigned a buy rating to the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $68.29.

SOLV has been the topic of a number of analyst reports. Mizuho initiated coverage on Solventum in a research note on Wednesday, December 4th. They set a "neutral" rating and a $70.00 price objective on the stock. Piper Sandler upped their price target on Solventum from $71.00 to $75.00 and gave the company a "neutral" rating in a research report on Friday, November 8th. Finally, Morgan Stanley raised their price objective on shares of Solventum from $60.00 to $73.00 and gave the company an "equal weight" rating in a research report on Monday, November 11th.

Institutional Investors Weigh In On Solventum

Several hedge funds have recently bought and sold shares of SOLV. Modus Advisors LLC bought a new position in shares of Solventum during the 4th quarter valued at about $25,000. Copeland Capital Management LLC purchased a new stake in Solventum in the third quarter worth approximately $26,000. Stonebridge Financial Group LLC bought a new position in Solventum during the fourth quarter valued at approximately $26,000. Mather Group LLC. purchased a new position in shares of Solventum during the third quarter worth approximately $27,000. Finally, Crews Bank & Trust purchased a new position in shares of Solventum during the fourth quarter worth approximately $32,000.

Solventum Price Performance

Shares of SOLV stock traded down $1.35 during trading on Tuesday, reaching $73.43. 859,465 shares of the company's stock traded hands, compared to its average volume of 970,471. The firm's 50-day moving average is $70.36 and its 200 day moving average is $67.80. Solventum has a 1 year low of $47.16 and a 1 year high of $96.05. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15.

Solventum (NYSE:SOLV - Get Free Report) last posted its earnings results on Thursday, November 7th. The company reported $1.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.38 by ($0.23). The business had revenue of $2.08 billion during the quarter, compared to analysts' expectations of $2.05 billion. As a group, sell-side analysts expect that Solventum will post 6.58 earnings per share for the current year.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.